CancerQuest | Interview with Dr. Brian Leyland-Jones

Brian Leyland-Jones
Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine

Dr. Leyland-Jones' main research interests are pharmacodynamics, pharmacokinetics and pharmacogenetics in oncological clinical trials; translation of preclinical models into the clinic; biomarker endpoints in Phase I/II clinical trials; and screening and mechanistic studies of novel targeted and chemotherapeutic anti-cancer agents.

Questions and Answers

	About Dr. Leyland-Jones(Time: 2 sec)
	Why did you become interested in cancer research?(Time: 47 sec)
	How will genotyping affect the development of individualized medicine?(Time: 1 min 43 sec)
	How will individualized medicine affect the pharmaceutical economy?(Time: 1 min 44 sec)
	How will individualized medicine affect insurance companies?(Time: 1 min 15 sec)
	What is the greatest challenge you face treating a breast cancer patient?(Time: 52 sec)
	What information should be given to a newly diagnosed cancer patient?(Time: 1 min 10 sec)
	How does molecular profiling affect educators and students studying cancer?(Time: 1 mni 12 sec)
	What is the future of molecular profiling process?(Time: 1 min 34 sec)
	What are your goals with genotyping or molecular profiling?(Time: 25 sec)